By Denny Jacob
Centene reported higher first-quarter revenue and membership enrollment for certain health insurance lines, but results were overshadowed by membership declines in Medicaid and Medicare.
Shares declined 1.8% to $60.46 in premarket trading Friday. The stock is up 1.8% on the year so far.
During the quarter, Centene said total Medicaid membership fell to 12.9 million from 13.3 million a year earlier, while Medicare membership, which includes Medicare Advantage and Medicare Supplement, fell to 1.04 million from 1.15 million a year earlier. Individual marketplace membership rose to 5.63 million from 4.35 million a year ago.
Other areas of Centene's results showed improvement.
The St. Louis health insurer said premium and services revenues increased 17% to $42.49 billion, primarily driven by premium and membership growth in the Medicare prescription drug plan business along with overall market growth in the marketplace business.
Health benefits ratio rose slightly to 87.5% in the quarter, from 87.1% a year earlier.
Looking ahead, Centene said it's raising its 2025 premium and service revenues guidance to a range of $164.0 billion to $166.0 billion due to higher-than-expected annual enrollment periods for Medicare Advantage and Marketplace.
Centene backed its 2025 expectations for earnings of at least $6.19 a share and adjusted earnings of at least $7.25 a share.
Centene logged earnings of $1.31 billion, or $2.63 a share, up from $1.16 billion, or $2.16 a share, in the prior-year period.
Stripping out certain one-time items, earnings came in at $2.90 a share. Analysts polled by FactSet expected $2.52 a share.
Revenue rose to $46.62 billion from $40.41 billion. Analysts polled by FactSet expected $42.76 billion.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 25, 2025 08:08 ET (12:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.